Brookfield Corporation (BN): Q4 2025 Results Breakdown
Price: $47 | Intrinsic Value (Management’s View): $68 | Discount: ~31%
Record Year, But Is The Stock Finally Cheap?
Brookfield just reported Q4 2025 results, and the numbers are strong. Record fundraising. Record asset sales. Record distributable earnings. Yet the stock sits at $47—a full 31% below management’s stated intrinsic value of $68 per share.
The question isn’t whether Brookfield had a good year (they did). The question is: At $47, is this finally a buy, or is there something broken under the hood?
Let’s break down the results and run the napkin math.
1. The Machine (What You’re Actually Buying)
Brookfield is a three-headed beast:
Engine #1: Asset Management (BAM)
$603 billion in fee-bearing capital (+12% YoY)
$112 billion raised in 2025 (record year)
Fee-related earnings: $3.0 billion (+22% YoY)
Annualized cash flow: $1.9 billion
Translation: This is the money printer. Every dollar of fee-bearing capital generates ~1.0% in fee-related earnings (after costs). And they just grew fee-bearing capital by $64 billion in one year. That’s $640 million of new annual earnings power added in 12 months.
Engine #2: Wealth Solutions (Insurance Float)
$143 billion in insurance assets
Annualized cash flow: $1.9 billion
15% ROE (down from 31% in 2023, but still world-class)
Net investment yield: 5.7%
Cost of funds: 3.5%
Gross spread: 2.25%
Translation: They collect insurance premiums (annuities, P&C), invest the float at 5.7%, and pay out 3.5%. The 2.25% spread generates $1.9 billion annually. This is Berkshire Hathaway’s playbook, but focused on real assets.
Engine #3: Operating Businesses
Renewable Power (BEP): $8.5 billion equity value
Infrastructure (BIP): $7.3 billion equity value
Private Equity (BBU): $3.2 billion equity value
Real Estate (BPG): $26.5 billion equity value
Total annualized cash flow: $1.5 billion
Translation: These are permanent capital vehicles that own toll roads, data centers, hydroelectric dams, and trophy office buildings. They throw off $1.5 billion in annual distributions to BN.
2. The Napkin Math: What’s It Worth?
Step 1: Add Up the Cash Flows
BusinessAnnualized Cash Flow
Asset Management (BAM)$1.9B
Wealth Solutions$1.9B
Operating Businesses$1.5B
Total (before corporate costs)$5.3B
Corporate costs & interest-$0.9B
Net Cash Flow $4.4B
Step 2: Adjust for Carry and Realizations
Brookfield has $11.6 billion of accumulated unrealized carried interest sitting on the balance sheet. Over the next 3 years, they expect to realize ~$6 billion of this (net of costs). That’s $2 billion/year of bonus cash flow.
Adjusted Annual Cash Flow: $4.4B + $2.0B = $6.4 billion
Step 3: Value the Business
Method 1: Multiple of Earnings
Blackstone (BX) trades at 25x P/E
KKR trades at 22x P/E
Apollo (APO) trades at 24x P/E
Brookfield’s Distributable Earnings (DE) = $6.0 billion (2025 actual, including realizations).
Current Market Cap = $103 billion
Current P/E = 17.2x (= $103B / $6.0B)
At 20x P/E (middle of peer range): $6.0B × 20 = $120 billion market cap
Implied share price: $120B / 2.38B shares = $50.42/share (+7% upside)
At 23x P/E (average of peers): $6.0B × 23 = $138 billion market cap
Implied share price: $138B / 2.38B shares = $58/share (+23% upside)
Method 2: Sum-of-the-Parts (Management’s Approach)
Management breaks it down like this:
BAM (69% stake): $61.5B (using $52.39/share × 1.19B shares)
Carried Interest (10x multiple on $2.7B net target carry): $27.0B
Wealth Solutions (15x annualized DE of $1.9B): $28.0B
Operating Businesses: $46.4B (market value of BEP, BIP, BBU, BPG)
Less: Corporate debt & preferred: -$18.6B
Total: $144 billion / 2.38B shares = $60.50/share
Management says $68. I’m getting $50-60 depending on method. Let’s split the difference and call it $55 fair value.
3. The Yield Calculation
At $47/share:
Free Cash Flow (DE before realizations): $5.4B
FCF per share: $5.4B / 2.38B = $2.27
FCF Yield: $2.27 / $47 = 4.83%
With Realizations (annualized $2B carry):
Total FCF: $5.4B + $2.0B = $7.4B
FCF per share: $7.4B / 2.38B = $3.11
FCF Yield: $3.11 / $47 = 6.62%
Comparison:
Risk-Free Rate (10Y Treasury): 4.5%
BN FCF Yield (with carry): 6.62%
Spread: +2.12%
You’re getting paid 212 basis points MORE than Treasuries for owning a diversified, inflation-protected, real asset machine with:
$188 billion of deployable capital
$112 billion raised in the last 12 months
30+ year track record of 19% annualized returns
4. The Growth Story
Historical Growth:
2021-2025 DE CAGR: 18%
Fee-bearing capital CAGR (2021-2025): 20%
Assets under management CAGR (30 years): 20%
Forward Projections:
Management targets:
Asset Management: 15% DE growth (driven by fee-bearing capital growth)
Wealth Solutions: 15% ROE (on growing equity base)
Operating Businesses: 5-9% distribution growth + asset recycling
Conservative Assumption: 12% blended DE growth over next 5 years.
Total Return=DE Growth (12%) + Dividend Yield (0.6%) + Buyback Yield (2.0%) = 14.6% CAGR
If P/E multiple expands from 17.2x (current) → 20x (peer average):
Add +3.1% annualized from multiple expansion.
12% + 0.6% + 2.0% + 3.1%=17.7% CAGR
12% + 0.6% + 2.0% + 3.1% =17.7% CAGR
5. The Risks (Why Is It Cheap?)
Complexity Discount:
Brookfield is hard to analyze. Three business lines, dozens of subsidiaries, cross-ownership between BAM/BWS/BEP/BIP/BBU. Retail investors don’t touch it. Institutional investors struggle to comp it (is it an asset manager? An insurance company? A REIT?). Result: 15-20% complexity discount vs. pure-play alternatives.
Illiquid Assets:
Most of the value is in private real estate, infrastructure, and private equity. You can’t mark these to market daily. In a crisis, this stuff gets hammered (see: 2020 COVID crash, when BN dropped 50%).
Leverage Concerns:
$259 billion of consolidated debt (though only $14.3B is recourse to the corporation). Investors see “debt” and freak out, even though 94% is non-recourse asset-level financing.
Management Incentives:
Bruce Flatt owns ~$500M+ in stock, but the comp structure is heavily weighted toward growing AUM (not necessarily shareholder returns). They love doing deals. Sometimes they overpay (see: Oaktree acquisition in 2019).
6. The Verdict
The “Sleep Well at Night” Score: 7.5/10
Why It’s Not a 10:
⚠️ Complexity: This is a PhD-level investment. If you can’t explain it to your spouse, you probably shouldn’t own it.
⚠️ Illiquidity: In a panic, this trades like a brick. Be prepared to hold through 20-30% drawdowns.
⚠️ Execution Risk: They have $188B to deploy. If they screw up capital allocation, returns crater.
Why It’s a 7.5:
✅ 30-year track record: $1 invested in 1995 = $285 today (19% CAGR).
✅ Fortress balance sheet: $188B deployable capital, A- credit rating.
✅ Inflation-protected assets: Real estate, infrastructure, renewables = natural inflation hedges.
✅ Recession-resistant: Asset management fees are sticky. Insurance float is permanent. Infrastructure assets are monopolies.
7. The One-Liner
“A $180 billion capital machine compounding at 15%+, run by the Canadian Warren Buffett, trading at 17x earnings. If you can stomach the complexity, this is an excellent company.”
8. The Action Plan
At $47 (current price):
P/E: 17.2x (vs. peer average of 23x)
FCF Yield: 6.62% (with carry)
Upside to fair value ($58 at 23x P/E): 23%
Upside to management’s intrinsic value ($68): 45%
Expected 5-year CAGR: 15-18%
What to Do:
$47-50: Start building a position (3-5% of portfolio)
$40-45: Increase to 7-10% of portfolio
Below $40: Max out (10-15% of portfolio)
What to Watch:
Fee-bearing capital growth: If it slows below 10%/year, that’s a red flag.
Carried interest realizations: They promised $6B over 3 years. If they miss, valuation takes a hit.
Wealth Solutions ROE: Currently 15%. If it drops below 12%, the growth story weakens.
Share buybacks: They bought back $1B in 2025 at $36/share (30% below intrinsic value). Smart capital allocation.
9. The Results: Good, Bad, or Ugly?
The Good:
✅ Fee-bearing capital growth: +12% YoY to $603B (this is the money printer)
✅ Fee-related earnings: +22% YoY to $3.0B (margins holding strong at ~58%)
✅ Fundraising: $112B raised (record year, driven by complementary strategies)
✅ Asset sales: $91B sold at or above carrying values (proves assets aren’t impaired)
✅ Balance sheet: $188B deployable capital, A- credit rating, fortress liquidity
✅ Wealth Solutions: Insurance assets grew to $143B (+$31B YoY), 15% ROE maintained
The Bad:
⚠️ Distributable Earnings per share: $2.54 (down 4% YoY from $2.64)
⚠️ Operating Businesses: DE down to $1.6B from $1.6B (flat, headwinds in real estate)
⚠️ Real Estate NOI: Down YoY due to dispositions (though super core occupancy strong at 96%)
⚠️ Wealth Solutions ROE: Down from 31.8% in 2023 to 25% (still world-class, but normalizing)
The Ugly:
❌ Stock price: Down from $60+ in early 2024 to $47 (market doesn’t believe the story)
❌ P/E at 17.2x: Trading below peers (BX at 25x, KKR at 22x, APO at 24x)
❌ Complexity: Still a black box for most investors (3 businesses, cross-ownership, illiquid assets)
Verdict on Results: Strong, but not spectacular. The asset management business is firing on all cylinders. Wealth Solutions is growing. Operating Businesses are flat but stable. The issue isn’t the results—it’s that the market is pricing in zero multiple expansion despite best-in-class peers trading at 22-25x P/E.
10. The Bottom Line
Brookfield reported strong Q4 2025 results, but the stock remains flat. The business is better than ever:
Record fundraising ($112B in 2025)
Record deployable capital ($188B)
Record DE ($6.0B)
Yet the stock trades at 17.2x P/E while peers trade at 22-25x P/E.
The market is pricing in:
❌ Complexity discount (3 businesses, illiquid assets, hard to analyze)
❌ Execution risk ($188B to deploy—if they screw up capital allocation, returns crater)
❌ Slower growth than peers (BX/KKR growing fee-bearing capital faster)
But the results say otherwise: Fee-bearing capital +12%, FRE +22%, $91B sold at/above carrying values.
For those willing to do the work, this is a 15-18% CAGR machine trading at a 25% discount to peers with a 6.6% FCF yield.
If you own it: Hold and add on dips below $45.
If you don’t: Start a position now. At 17x P/E with 12% growth, the math works.
Disclaimer: This is not financial advice. I’m just a dude with a spreadsheet and a love for complex holding companies.